These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 8428368)
1. The role of cathepsin D in the invasiveness of human breast cancer cells. Johnson MD; Torri JA; Lippman ME; Dickson RB Cancer Res; 1993 Feb; 53(4):873-7. PubMed ID: 8428368 [TBL] [Abstract][Full Text] [Related]
2. [Estrogens, cathepsin D and metastasis in cancers of the breast and ovary: invasion or proliferation?]. Rochefort H C R Seances Soc Biol Fil; 1998; 192(2):241-51. PubMed ID: 9841098 [TBL] [Abstract][Full Text] [Related]
3. Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines. Thompson EW; Paik S; Brünner N; Sommers CL; Zugmaier G; Clarke R; Shima TB; Torri J; Donahue S; Lippman ME J Cell Physiol; 1992 Mar; 150(3):534-44. PubMed ID: 1537883 [TBL] [Abstract][Full Text] [Related]
4. Differential expression of the mannose 6-phosphate/ insulin-like growth factor-II receptor in human breast cancer cell lines of different invasive potential. Xie S; Kang JX Med Sci Monit; 2002 Aug; 8(8):BR293-300. PubMed ID: 12165733 [TBL] [Abstract][Full Text] [Related]
5. Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells. Kang H; Mansel RE; Jiang WG Int J Oncol; 2005 May; 26(5):1429-34. PubMed ID: 15809737 [TBL] [Abstract][Full Text] [Related]
6. In vitro degradation of extracellular matrix with Mr 52,000 cathepsin D secreted by breast cancer cells. Briozzo P; Morisset M; Capony F; Rougeot C; Rochefort H Cancer Res; 1988 Jul; 48(13):3688-92. PubMed ID: 3378211 [TBL] [Abstract][Full Text] [Related]
7. [The presence of large acidic vesicles is correlated with in vitro invasive potential of breast cancer cells]. Montcourrier P; Valembois C; Rochefort H C R Acad Sci III; 1993; 316(4):421-4. PubMed ID: 8402270 [TBL] [Abstract][Full Text] [Related]
8. Down-regulation of cathepsin-D expression by antisense gene transfer inhibits tumor growth and experimental lung metastasis of human breast cancer cells. Glondu M; Liaudet-Coopman E; Derocq D; Platet N; Rochefort H; Garcia M Oncogene; 2002 Aug; 21(33):5127-34. PubMed ID: 12140763 [TBL] [Abstract][Full Text] [Related]
9. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis. Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070 [TBL] [Abstract][Full Text] [Related]
10. A molecular role for lysyl oxidase in breast cancer invasion. Kirschmann DA; Seftor EA; Fong SF; Nieva DR; Sullivan CM; Edwards EM; Sommer P; Csiszar K; Hendrix MJ Cancer Res; 2002 Aug; 62(15):4478-83. PubMed ID: 12154058 [TBL] [Abstract][Full Text] [Related]
11. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB. Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities. Tan M; Yao J; Yu D Cancer Res; 1997 Mar; 57(6):1199-205. PubMed ID: 9067293 [TBL] [Abstract][Full Text] [Related]
13. Increased secretion, altered processing, and glycosylation of pro-cathepsin D in human mammary cancer cells. Capony F; Rougeot C; Montcourrier P; Cavailles V; Salazar G; Rochefort H Cancer Res; 1989 Jul; 49(14):3904-9. PubMed ID: 2736531 [TBL] [Abstract][Full Text] [Related]
14. Biological and clinical significance of cathepsin D in breast cancer metastasis. Garcia M; Platet N; Liaudet E; Laurent V; Derocq D; Brouillet JP; Rochefort H Stem Cells; 1996 Nov; 14(6):642-50. PubMed ID: 8948022 [TBL] [Abstract][Full Text] [Related]
15. Procathepsin D expression correlates with invasive and metastatic phenotype of MDA-MB-231 derived cell lines. Ohri SS; Vashishta A; Vetvickova J; Fusek M; Vetvicka V Int J Biol Macromol; 2007 Jul; 41(2):204-9. PubMed ID: 17397917 [TBL] [Abstract][Full Text] [Related]
16. Role of CCL5 in invasion, proliferation and proportion of CD44+/CD24- phenotype of MCF-7 cells and correlation of CCL5 and CCR5 expression with breast cancer progression. Zhang Y; Yao F; Yao X; Yi C; Tan C; Wei L; Sun S Oncol Rep; 2009 Apr; 21(4):1113-21. PubMed ID: 19288016 [TBL] [Abstract][Full Text] [Related]
17. Biological and clinical significance of cathepsin D in breast cancer. Rochefort H Semin Cancer Biol; 1990 Apr; 1(2):153-60. PubMed ID: 2103491 [TBL] [Abstract][Full Text] [Related]
18. Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells. Cos S; Fernández R; Güézmes A; Sánchez-Barceló EJ Cancer Res; 1998 Oct; 58(19):4383-90. PubMed ID: 9766668 [TBL] [Abstract][Full Text] [Related]
19. Chemically modified tetracyclines inhibit VEGF secretion by breast cancer cell lines. Kothari M; Simon SR Cytokine; 2006 Aug; 35(3-4):115-25. PubMed ID: 16978872 [TBL] [Abstract][Full Text] [Related]
20. Primary breast myoepithelial cells exert an invasion-suppressor effect on breast cancer cells via paracrine down-regulation of MMP expression in fibroblasts and tumour cells. Jones JL; Shaw JA; Pringle JH; Walker RA J Pathol; 2003 Dec; 201(4):562-72. PubMed ID: 14648659 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]